BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Diagnosis
44 results:

  • 1. BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms.
    Gerami P; Chen A; Sharma N; Patel P; Hagstrom M; Kancherla P; Geraminejad T; Olivares S; Biswas A; Bosenberg M; Busam KJ; de La Fouchardière A; Duncan LM; Elder DE; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Mihic-Probst D; Parker DC; Scolyer RA; Shea CR; Zembowicz A; Yun SJ; Blokx WAM; Barnhill RL
    Am J Surg Pathol; 2024 May; 48(5):538-545. PubMed ID: 38525831
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spitz tumor with RAF1 fusion: A report of 3 cases.
    Donati M; Nosek D; Olivares S; Lemahieu J; Loontiens S; Mansour B; Gerami P; Kazakov DV
    Ann Diagn Pathol; 2023 Dec; 67():152215. PubMed ID: 37856952
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1.
    Fumero-Velázquez M; Hagstrom M; Dhillon S; Geraminejad T; Olivares S; Donati M; Nosek D; Waldenbäck P; Kazakov D; Sheffield BS; Tron VA; Gerami P
    Am J Surg Pathol; 2023 Dec; 47(12):1438-1448. PubMed ID: 37773074
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Agminated presentation of fusion-driven melanocytic neoplasms.
    Fumero-Velázquez M; Hagstrom M; Dhillon S; Olivares S; Jennings LJ; Dittman D; Sukhanova M; Arva NC; Goldstein SD; Theos A; Pavlidakey P; Carr Z; Gerami P
    J Cutan Pathol; 2023 Oct; 50(10):913-921. PubMed ID: 37407520
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases.
    Mansour B; Vanecek T; Kastnerova L; Nosek D; Kazakov DV; Donati M
    Am J Dermatopathol; 2023 May; 45(5):306-310. PubMed ID: 36939120
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An update on genomic aberrations in Spitz naevi and tumours.
    Hagstrom M; Fumero-Velázquez M; Dhillon S; Olivares S; Gerami P
    Pathology; 2023 Mar; 55(2):196-205. PubMed ID: 36631338
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Next-generation Sequencing as a Potential Diagnostic Adjunct in Distinguishing Between Desmoplastic Melanocytic Neoplasms.
    Roth A; Boutko A; Lampley N; Dhillon S; Hagstrom M; Olivares S; Dittman D; Jennings L; Santana Dos Santos L; Busam K; Gerami P
    Am J Surg Pathol; 2023 Mar; 47(3):318-325. PubMed ID: 36383901
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Sebaceous nevus of Jadassohn: review and clinical-surgical approach.
    Neto MPDS; Assis BR; Andrade GR
    An Bras Dermatol; 2022; 97(5):628-636. PubMed ID: 35863943
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders.
    Atzmony L; Ugwu N; Hamilton C; Paller AS; Zech L; Antaya RJ; Choate KA
    Pediatr Dermatol; 2022 Nov; 39(6):903-907. PubMed ID: 35853659
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Benign and Intermediate-grade Melanocytic Tumors With BRAF Mutations and Spitzoid Morphology: A Subset of Melanocytic Neoplasms Distinct From Melanoma.
    Zhao J; Benton S; Zhang B; Olivares S; Asadbeigi S; Busam K; Gerami P
    Am J Surg Pathol; 2022 Apr; 46(4):476-485. PubMed ID: 34753863
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of a recurrent mosaic
    Green TE; MacGregor D; Carden SM; Harris RV; Hewitt CA; Berkovic SF; Penington AJ; Scheffer IE; Hildebrand MS
    Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34649968
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.
    Parra O; Lefferts JA; Tafe LJ; Gru AA; Linos K
    Hum Pathol; 2021 Jun; 112():35-47. PubMed ID: 33636207
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
    Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
    Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Modified pedicled anterolateral thigh myocutaneous flap for large full-thickness abdominal defect reconstruction].
    Song D; Li Z; Zhou X; Zhang Y; Peng X; Zhou B; Lü C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2019 Oct; 33(10):1305-1309. PubMed ID: 31544444
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer.
    Liu J; Liu X; He J; Gou B; Luo Y; Deng S; Wen H; Zhou L
    Sci Rep; 2019 Sep; 9(1):13545. PubMed ID: 31537856
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary and secondary mucosal melanoma of the small intestine - a clinical, pathological, and genetic nationwide survey of Danish patients between 1980 and 2014.
    Tingsgaard JK; Henriksen A; Mikkelsen LH; Behrendt N; Melchior LC; Svendsen LB; Heegaard S
    APMIS; 2018 Sep; 126(9):739-745. PubMed ID: 30160023
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
    Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
    Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pigmented trichoblastoma developed in a sebaceous nevus: hras mutation as a common molecular driver.
    Saraggi D; Salmaso R; Valentini E; Munari G; Vindigni V; Rugge M; Fassan M; Cerroni L
    Pathol Res Pract; 2017 Jul; 213(7):860-862. PubMed ID: 28554764
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.